Lu, C., Tsai, H., Uen, Y., Hu, H., Chen, C., Cheng, T., . . . Wang, J. (2013). Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer. Nature Publishing Group.
Citação norma ChicagoLu, C-Y, H-L Tsai, Y-H Uen, H-M Hu, C-W Chen, T-L Cheng, S-R Lin, and J-Y Wang. Circulating Tumor Cells As a Surrogate Marker for Determining Clinical Outcome to MFOLFOX Chemotherapy in Patients With Stage III Colon Cancer. Nature Publishing Group, 2013.
Citação norma MLALu, C-Y, et al. Circulating Tumor Cells As a Surrogate Marker for Determining Clinical Outcome to MFOLFOX Chemotherapy in Patients With Stage III Colon Cancer. Nature Publishing Group, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.